Susquehanna International Group, LLP Madrigal Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

25 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$212.22 - $292.96 $22.5 Million - $31 Million	-105,800 Reduced 31.32%	232,000 $49.2 Million
Q2 2024 Aug 15, 2024	SELL	$193.33 - $291.99 $17.9 Million - $27.1 Million	-92,700 Reduced 21.53%	337,800 $94.6 Million
Q1 2024 May 07, 2024	BUY	$171.37 - $283.23 $33.5 Million - $55.3 Million	195,400 Added 83.11%	430,500 $115 Million
Q4 2023 Feb 14, 2024	SELL	$120.4 - $237.13 $16.4 Million - $32.2 Million	-135,900 Reduced 36.63%	235,100 $54.4 Million
Q3 2023 Nov 14, 2023	SELL	$146.04 - $225.78 $686,388 - $1.06 Million	-4,700 Reduced 1.25%	371,000 $54.2 Million
Q2 2023 Aug 11, 2023	BUY	$203.88 - $312.0 $25.4 Million - $38.8 Million	124,400 Added 49.5%	375,700 $86.8 Million
Q1 2023 May 16, 2023	BUY	$231.06 - $307.08 $6.77 Million - $9 Million	29,300 Added 13.2%	251,300 $60.9 Million
Q4 2022 Feb 14, 2023	BUY	$58.39 - $296.54 $10.9 Million - $55.2 Million	186,000 Added 516.67%	222,000 $64.4 Million
Q3 2022 Nov 14, 2022	SELL	$60.57 - $79.51 $1.13 Million - $1.49 Million	-18,700 Reduced 34.19%	36,000 $2.34 Million
Q2 2022 Aug 15, 2022	BUY	$58.04 - $100.2 $2.17 Million - $3.75 Million	37,400 Added 216.18%	54,700 $3.92 Million
Q1 2022 May 16, 2022	SELL	$55.89 - $101.89 $838,350 - $1.53 Million	-15,000 Reduced 46.44%	17,300 $1.7 Million
Q4 2021 Feb 14, 2022	BUY	$72.34 - $95.09 $484,678 - $637,103	6,700 Added 26.17%	32,300 $2.74 Million
Q3 2021 Nov 15, 2021	BUY	$78.35 - $105.02 $1.31 Million - $1.75 Million	16,700 Added 187.64%	25,600 $2.04 Million
Q2 2021 Aug 11, 2021	BUY	$97.2 - $137.59 $87,480 - $123,831	900 Added 11.25%	8,900 $867,000
Q1 2021 May 17, 2021	BUY	$108.54 - $125.2 $65,124 - $75,120	600 Added 8.11%	8,000 $936,000
Q4 2020 Feb 16, 2021	SELL	$110.06 - $133.7 $1.8 Million - $2.19 Million	-16,400 Reduced 68.91%	7,400 $823,000
Q3 2020 Nov 16, 2020	SELL	$99.78 - $124.21 $1.81 Million - $2.25 Million	-18,100 Reduced 43.2%	23,800 $2.83 Million
Q2 2020 Aug 14, 2020	BUY	$60.13 - $125.71 $2.16 Million - $4.53 Million	36,000 Added 610.17%	41,900 $4.75 Million
Q1 2020 May 15, 2020	SELL	$66.76 - $93.49 $647,572 - $906,853	-9,700 Reduced 62.18%	5,900 $394,000
Q3 2019 Nov 14, 2019	SELL	$84.4 - $106.53 $2.84 Million - $3.58 Million	-33,600 Reduced 68.29%	15,600 $1.35 Million
Q2 2019 Aug 14, 2019	SELL	$91.13 - $142.5 $7.69 Million - $12 Million	-84,400 Reduced 63.17%	49,200 $5.16 Million
Q1 2019 May 15, 2019	SELL	$103.48 - $143.84 $4.85 Million - $6.75 Million	-46,900 Reduced 25.98%	133,600 $16.7 Million
Q4 2018 Feb 14, 2019	BUY	$94.77 - $215.54 $1.16 Million - $2.63 Million	12,200 Added 7.25%	180,500 $20.3 Million
Q3 2018 Nov 14, 2018	BUY	$207.3 - $300.31 $8.6 Million - $12.5 Million	41,500 Added 32.73%	168,300 $36 Million
Q2 2018 Aug 14, 2018	BUY	$101.55 - $313.9 $12.9 Million - $39.8 Million	126,800 New	126,800 $35.5 Million

Others Institutions Holding MDGL

# of Institutions

297

Shares Held

22M

Call Options Held

819K

Put Options Held

640K

Janus Henderson Group PLC London, X0

2.48M
Shares

$773 Million
0.28% of portfolio
John Paulson Paulson & Co. Inc. | New York, Ny

2.04M
Shares

$637 Million
29.57% of portfolio
Avoro Capital Advisors LLC New York, NY

2.03M
Shares

$633 Million
6.48% of portfolio
Rtw Investments, LP New York, NY

1.99M
Shares

$622 Million
6.74% of portfolio
Baker Bros. Advisors LP New York, NY

1.97M
Shares

$616 Million
4.49% of portfolio

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.34B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account